Company intelligence / Profile preview

Gabri Labs

Dover, Delaware, United Statesgabrilabs.com ↗

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

Gabri Labs produces medical devices and over-the-counter products focused on ENT and dermatology therapeutic areas. Their Dubai facility was planned to produce up to 12 million units per year with further expansions planned by 2023.

Therapeutic areas: OtherDermatology
Modalities: Medical devicesOver-the-counter products
Industry: Therapeutic Medical Devices

Drug pipeline

2 assets

OTOMAR

Commercial

Indications: ENT disorders, Nasal care

1 more asset in the full pipeline.

Request access →

Partnerships

Dubai Science Park

Beyond the preview

Go deeper on Gabri Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gabri Labs.

Explore the full profile